Pharmaceutical
Technology
Health

Quidel

$65.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.04 (1.62%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Quidel and other stocks, options, ETFs, and crypto commission-free!

About

Quidel Corp. engages in the development, manufacture, and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. Read More The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Employees
1,224
Headquarters
San Diego, California
Founded
1979
Market Cap
2.52B
Price-Earnings Ratio
35.63
Dividend Yield
0.00
Average Volume
290.74K
High Today
$65.58
Low Today
$64.16
Open Price
$64.66
Volume
79.06K
52 Week High
$77.63
52 Week Low
$44.27

Collections

Pharmaceutical
Technology
Health
Medical
Retail
Pharmacies
US
North America

News

BenzingaMar 6

Immunoassay Market Size Worth $25.41 Billion by 2025 | CAGR: 5.0%: Grand View Research, Inc.

SAN FRANCISCO, March 6, 2019 /PRNewswire/ -- The global immunoassay market size is expected to reach USD 25.41 billion by 2025, according to a new report by Grand View Research, Inc.

33
Yahoo FinanceMar 4

What Are Analysts Saying About Quidel Corporation’s (NASDAQ:QDEL) Growth?

Looking at Quidel Corporation’s (NASDAQ:QDEL) earnings update on 31 December 2018, analysts seem cautiously optimistic, as a 21% increase in profits is expected in the upcoming year, though this is relatively lower than the previous 5-year average earnings growth of 59%. Currently with trailing-twelve-month earnings of US$74m, we can expect this to reach US$90m by 2020. Below is a brief commentary around Quidel’s earnings outlook going forward, which may give you a sense of market sentiment for the company.

10
Markets InsiderFeb 26

Quidel to Present at Upcoming Conferences

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the following upcoming conferences: Raymond James & Associates 40 th Annual Institutional Investors Conference to be held at the J.W. Marriott Grande Lakes hotel in Orlando, Florida on Wednesday, March 6, 2019 at 12:10 p.m. Eastern Time (9:10 a.m. Pacific Time). Annual Institutional Investors Conference to be held at t...

9

Earnings

-$0.18
$0.31
$0.80
$1.29
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected May 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.